Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-03 01:04:51 - browse：98

Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed.

In the trial, 404 patients with the disorder, IgA nephropathy, were randomized to receive either Travere’s daily pill, Filspari, or irbesartan, a decades-old blood pressure drug often used to help manage the disease. Early data had showed the drug cut protein levels in the urine, a biomarker of kidney function, by half after nine months. That convinced regulators to give Filspari accelerated approval in February, pending full results using a more direct measure of kidney function.

The new data, after 24 months, showed that patients who received Filspari declined less quickly than those in the control group. But the results just missed statistical significance, with a P value of 0.058.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： He's 19 months old and has one of the world’s rarest diseases

knowledge

WSS

For AI in health care standards, federal regulators join with industry group

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Pregnant women don't need prenatal multivitamins, study concludes

Eliminate the waiting period for sterilization covered by Medicaid

Scientists boost immune system in aging mice by making it youthful

Medicare drug price negotiation hearing pits pharma v Biden admin

hotspot

Wikipedia

focus

Alkermes shareholders re

Florida health officials providing scant details on measles cases

BioMarin wins approval for gene therapy to treat hemophilia A

Merck drug for rare lung condition set for approval in U.S.

Duchenne breakthrough therapy leaves behind pioneering families

Covid vaccine financial winners and losers, from Pfizer to Novavax

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Scientists boost immune system in aging mice by making it youthful

United colonoscopy coverage change 'may cost lives,' doctors say

Longer MASH drug regimen improved liver, Akero study finds

entertainment

Merck drug for rare lung condition set for approval in U.S.

Abortion pill Supreme Court ruling could impact entire drug industry

Covid vaccine financial winners and losers, from Pfizer to Novavax

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Biden's 'march

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

hotspot

knowledge

Wikipedia

entertainment